Yeah I'm not 100% familiar with the potential case here but I'd imagine it's in everyone's best interest to ensure that the medicine is not hindered in its ability to be manufactured and delivered and that the company that holds patents on the delivery vehicle (LNP) would be compensated justly.

It isn't a new thing for what it's worth. Going back to earlier this year it has been looked at, but we don't really have a clear picture on what will shake out.